| In Vivo Molecular Imaging for Clinical Trials | ||
| 08-01-09 Hit 3,861 | ||
This course will delineate the core concepts of in vivo molecular imaging including PET , SPECT, MRI, MRS, CT and optical or bioluminescence imaging as well as radioimmunology. It will be discussed in detail how to apply these methodology to conduct clinical trials using new radiopharmaceuticals such as Tc-99m labeled DG, GP, adenosine, guanine, nitroimidazole, annexin-V, VEGFR and taxol, gemcitabine, aricept or celebrex.